Re: I don’t get it
|
4
|
Resverlogix Corp.
|
May 23, 2019 01:13PM
|
Re: Zacks new analyst research update price increase and buy rating
|
4
|
Resverlogix Corp.
|
Jan 19, 2016 01:04PM
|
Re: I believe the big/long wait
|
4
|
Resverlogix Corp.
|
Aug 24, 2023 06:19PM
|
Re: We need safe and effective Covid therapies
|
4
|
Resverlogix Corp.
|
Sep 29, 2021 09:05AM
|
Re: AGM
|
4
|
Resverlogix Corp.
|
Jun 30, 2023 09:48AM
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 02:55PM
|
Re: Questions for Q1 webcast
|
4
|
Resverlogix Corp.
|
Mar 05, 2016 12:45PM
|
Re: Yes , it seems like a hundred years ago...
|
4
|
Resverlogix Corp.
|
Mar 07, 2021 04:53PM
|
Re: Financial Statement Q2, 2023 /MD&A
|
4
|
Resverlogix Corp.
|
Aug 13, 2023 12:27AM
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 21, 2020 01:28PM
|
Re: American Society of Nephrology Kidney Week
|
4
|
Resverlogix Corp.
|
Nov 04, 2017 02:42PM
|
Re: no lack of passion for RVX, it's just on hold...
|
4
|
Resverlogix Corp.
|
Nov 13, 2017 02:36PM
|
Re: RVV insider purchases
|
4
|
Resverlogix Corp.
|
Dec 12, 2022 08:30PM
|
Re: Does anyone know the record date for incentive stock options?
|
4
|
Resverlogix Corp.
|
Sep 29, 2016 08:24PM
|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
4
|
Resverlogix Corp.
|
Jan 18, 2016 06:12PM
|
Re: Disease X
|
4
|
Resverlogix Corp.
|
Jan 22, 2024 01:45PM
|
Re: 3rd Qtr MD&A & Financials
|
4
|
Resverlogix Corp.
|
Jan 09, 2024 11:58AM
|
RVX Market Price
|
4
|
Resverlogix Corp.
|
Mar 10, 2017 12:17PM
|
Re: Extended Betonmace trial
|
4
|
Resverlogix Corp.
|
Apr 20, 2017 06:05PM
|
Re: Extended Betonmace trial
|
4
|
Resverlogix Corp.
|
Apr 20, 2017 07:01PM
|